President Obama’s 1-million-person health study kicks off with five recruitment centers
By Jocelyn Kaiser,
Science Magazine
| 07. 07. 2016
President Barack Obama’s ambitious 1-million-person personalized medicine study began to take shape this week with the announcement of four medical centers that will recruit volunteers starting this fall. A fifth center aims to sign up 350,000 participants by blasting the general public with ads coming soon to your web browser or mobile phone.
The White House’s announcement yesterday of $55 million in awards from the National Institutes of Health (NIH) fires the starting gun for the Precision Medicine Initiative (PMI) Cohort Program. The plan is to recruit 1 million or more people who are willing to share their health and genetic information over many years to help researchers develop individualized treatments. Other countries have similar studies underway, but the U.S. version aims to be larger, more diverse, and more patient-centric—participants will help shape the study and be able to see their data. NIH Director Francis Collins calls it “the largest, most ambitious research project of this sort ever undertaken.”
President Obama, who first announced the PMI in January 2015, writes today in The Boston Globe that “the ensuing breakthroughs” from...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
